Objective:

To evaluate the effectiveness of DNA sequencing of colorectal polyps and cancers in clarifying cases of adenomatous or serrated polyposis that remain unexplained by standard genetic testing.

Approach:

Key Findings:

• Mosaic APC alterations were identified in 19% of patients with adenomatous and mixed polyposis.
• APC mutations were found in 73% of adenomas, while BRAF p.(Val600Glu) mutations were present in 79% of serrated polyps.
• Only 9% of serrated polyps were classified as CIMP-high, with low tumor mutational burden observed.

Interpretation:

Somatic testing of colorectal lesions can provide critical insights into the genetic basis of polyposis, particularly in identifying mosaic variants that are missed by traditional germline testing.

Limitations:

• The study may not encompass all genetic variations present in colorectal polyps.
• Findings are based on a specific cohort and may not be generalizable to all populations.

Conclusion:

Somatic DNA sequencing of colorectal polyps can enhance diagnostic accuracy for polyposis patients and uncover previously undetected genetic alterations.

Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.